Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
Cash from Investing Activities
Shin Nippon Biomedical Laboratories Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Cash from Investing Activities
-¥7B
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
-23%
|
CMIC Holdings Co Ltd
TSE:2309
|
Cash from Investing Activities
¥2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medinet Co Ltd
TSE:2370
|
Cash from Investing Activities
¥3.3m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
-40%
|
|
CellSource Co Ltd
TSE:4880
|
Cash from Investing Activities
-¥624.1m
|
CAGR 3-Years
-121%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Cash from Investing Activities
¥31.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WDB coco Co Ltd
TSE:7079
|
Cash from Investing Activities
-¥303m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-118%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Cash from Investing Activities?
Cash from Investing Activities
-7B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Cash from Investing Activities amounts to -7B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-23%
Over the last year, the Cash from Investing Activities growth was 3%. The average annual Cash from Investing Activities growth rates for Shin Nippon Biomedical Laboratories Ltd have been -76% over the past three years , -71% over the past five years , and -23% over the past ten years .